Loading...
•
Dec 31, 2024
ICON Q4 2024 Earnings Report
ICON reported a decline in revenue but saw an increase in net income and adjusted EPS for Q4 2024.
Key Takeaways
ICON reported Q4 2024 revenue of $2.04 billion, a 1.2% decrease from the prior year. Net income increased to $260 million, and adjusted EPS reached $3.43. The company also reported strong free cash flow and reaffirmed its full-year 2025 financial guidance.
Revenue for Q4 2024 was $2.04 billion, down 1.2% year-over-year.
Net income increased 21.5% to $260 million.
Adjusted EPS reached $3.43, slightly down from $3.46 in Q4 2023.
Free cash flow met the full-year target of $1.1 billion.
ICON
ICON
Forward Guidance
ICON reaffirmed its full-year 2025 revenue guidance between $8.05 billion and $8.65 billion and adjusted diluted EPS between $13.00 and $15.00.
Positive Outlook
- Full-year 2025 revenue guidance reaffirmed at $8.05-$8.65 billion.
- Adjusted diluted EPS expected to be between $13.00 and $15.00.
- Strong cash flow expected to support business operations.
- Continued demand growth in pharma and biotech sectors.
- New share repurchase program of up to $750 million approved.
Challenges Ahead
- Revenue declined by 1.2% compared to Q4 2023.
- Adjusted EPS slightly declined from Q4 2023.
- Increased costs and expenses impacting margins.
- Macroeconomic volatility could affect business operations.
- Ongoing restructuring and integration efforts may add costs.